You’re offline. This is a read only version of the page.
Toggle navigation
Research Registry
Research Registry
Browse the Research Registry
Search the Research Registry
Useful links
Useful links
Public Data Browser
Support for funding applications
PanelApp
Research Environment User Guide
Research Environment videos
Research Environment Training Sessions
Help
Help
Service Desk
Research Environment User Guide
For the public
All
All
Web Pages
Search Filter
All
Web Pages
Search
Sign in
Research Portal
Home
Research Registry
Browse the Research R...
Browse the research registry public
Browse the research registry
In this section
Browse the Research Registry
Search the Research Registry
Research registry ID
*
Date submitted
*
Project lead
Title
*
Investigating the differences in severity of monegenic protein lipidation disorders
Project type
Genomics England
Research Network - academic
Research Network - industry
Project start date
*
Institution Details
Community 1
*
Community 2
Community 3
Lay summary
*
Some rare developmental conditions are caused by problems in a process called protein lipidation. This process involves adding or removing fat molecules from proteins so they reach the correct place in the cell at the right time. It is especially important in the brain. When lipidation does not work properly, individuals may develop learning difficulties, seizures, movement problems, or other health issues. At present, most of these conditions are studied one at a time, so it is unclear whether people with different lipidation disorders share similar symptoms or patterns of severity. This project aims to study these conditions together to improve understanding, diagnosis, and future care. The research will use existing, anonymous genetic and clinical information from people with lipidation-related developmental conditions. No new data will be collected from participants. Health features will be grouped into broad body systems, such as the nervous system, heart, growth, and muscles. Each person’s condition will then be assessed based on how symptoms affect daily life, whether they worsen over time, and whether they pose serious health risks. The study will compare severity patterns across different lipidation conditions and explore possible biological reasons for any differences. This work may help clinicians recognise shared clinical needs and support patients and families more effectively. There is minimal risk, as only de-identified data are used. Without this research, these rare conditions may continue to be studied in isolation, limiting progress in understanding and care.